Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 24, Pages 9568
Publisher
MDPI AG
Online
2020-12-16
DOI
10.3390/ijms21249568
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting cancer stem cells from a metabolic perspective
- (2020) Yao-An Shen et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Patterns of stemness‐associated markers in the development of castration‐resistant prostate cancer
- (2020) Joël R. Federer‐Gsponer et al. PROSTATE
- Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells
- (2020) Belén G. Sánchez et al. Cells
- Reprogramming Prostate Cancer Cells into Induced Pluripotent Stem Cells: a Promising Model of Prostate Cancer Stem Cell Research
- (2020) Yiming Zhang et al. Cellular Reprogramming
- Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer Model
- (2019) Shiv Verma et al. Frontiers in Genetics
- Sox2: A regulatory factor in tumorigenesis and metastasis
- (2019) Sameer Chaudhary et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Treatment of Metastatic Castration-resistant Prostate Cancer With Abiraterone and Enzalutamide Despite PSA Progression
- (2019) DANIEL J. BECKER et al. ANTICANCER RESEARCH
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
- (2019) Ian D. Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
- (2019) David Rodriguez et al. Cancers
- SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond
- (2019) Thorsten Schaefer et al. ONCOGENE
- Elimination of SOX2/OCT4-Associated Prostate Cancer Stem Cells Blocks Tumor Development and Enhances Therapeutic Response
- (2019) Prasanna Kumar Vaddi et al. Cancers
- Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics
- (2018) Rajnee Kanwal et al. CANCER LETTERS
- Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer
- (2018) Nobuaki Matsubara et al. Clinical Genitourinary Cancer
- Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment
- (2018) Gerhardt Attard et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
- (2018) Matti Annala et al. Cancer Discovery
- Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
- (2018) Qiuhui Li et al. Nature Communications
- Common metabolic pathways implicated in resistance to chemotherapy point to a key mitochondrial role in breast cancer
- (2018) Etna Abad et al. MOLECULAR & CELLULAR PROTEOMICS
- Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review
- (2017) Bede van Schaijik et al. JOURNAL OF CLINICAL PATHOLOGY
- Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison
- (2017) Akhil Chopra et al. PROSTATE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- The dark side of SOX2: cancer - a comprehensive overview
- (2017) Erin L. Wuebben et al. Oncotarget
- REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer
- (2017) Yi-Ting Chang et al. Scientific Reports
- SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells
- (2016) F. Handle et al. MOLECULAR CANCER RESEARCH
- Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition
- (2016) Safeena Kulsum et al. MOLECULAR CARCINOGENESIS
- Aldehyde dehydrogenase 1A1 in stem cells and cancer
- (2016) Hiroyuki Tomita et al. Oncotarget
- Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets
- (2016) Sari Toropainen et al. Scientific Reports
- BDE-209 inhibits pluripotent genes expression and induces apoptosis in human embryonic stem cells
- (2015) Lili Du et al. JOURNAL OF APPLIED TOXICOLOGY
- Inhibitory action of pristimerin on hypoxia-mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells
- (2015) JIANWEI ZUO et al. ONCOLOGY REPORTS
- Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
- (2015) Tiyasha H. Ayub et al. Oncotarget
- Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer
- (2015) Sindy Magnan et al. JAMA Oncology
- Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
- (2015) Diane Ojo et al. Cancers
- Dedifferentiation and reprogramming: origins of cancer stem cells
- (2014) D. Friedmann-Morvinski et al. EMBO REPORTS
- Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial
- (2014) Karim Fizazi et al. LANCET ONCOLOGY
- OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma
- (2013) Lu Cao et al. BMC CANCER
- Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
- (2013) Prabhakar Rajan et al. EUROPEAN UROLOGY
- A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer
- (2013) Andrea Lunardi et al. NATURE GENETICS
- Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
- (2013) Steven Kregel et al. PLoS One
- Human amniotic epithelial cell feeder layers maintain iPS cell pluripotency by inhibiting endogenous DNA methyltransferase 1
- (2013) QING CHEN et al. Experimental and Therapeutic Medicine
- Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care?
- (2012) L. Klotz et al. Current Oncology
- Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties
- (2012) Linlin Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Gene Expression Profiles of Prostate Cancer Stem Cells Isolated by Aldehyde Dehydrogenase Activity Assay
- (2012) Sachiyo Nishida et al. JOURNAL OF UROLOGY
- Oct4 and Nanog Directly Regulate Dnmt1 to Maintain Self-Renewal and Undifferentiated State in Mesenchymal Stem Cells
- (2012) Chih-Chien Tsai et al. MOLECULAR CELL
- Global DNA Hypomethylation Prevents Consolidation of Differentiation Programs and Allows Reversion to the Embryonic Stem Cell State
- (2012) Christine S. Schmidt et al. PLoS One
- Reprogramming of prostate cancer-associated stromal cells to embryonic stem-like
- (2012) Eneida F. Vêncio et al. PROSTATE
- Novel Live Alkaline Phosphatase Substrate for Identification of Pluripotent Stem Cells
- (2012) Upinder Singh et al. Stem Cell Reviews and Reports
- HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
- (2011) J. Mathieu et al. CANCER RESEARCH
- Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system
- (2011) Huai-En Lu et al. EXPERIMENTAL CELL RESEARCH
- Mantle cell lymphoma activation enhances bortezomib sensitivity
- (2010) S. K. Brennan et al. BLOOD
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells
- (2010) Jianchang Yang et al. PLoS One
- Exploring the Origins of the Normal Prostate and Prostate Cancer Stem Cell
- (2008) Susan Kasper Stem Cell Reviews and Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now